Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

SAN:FP

82.0000 EUR 0.2600 0.32%

As of 11:36:13 ET on 01/30/2015.

Snapshot for Sanofi (SAN)

Open: 82.9400 Day's Range: 81.3700 - 83.0300 Volume: 3,876,370
Previous Close: 82.2600 52wk Range: 68.2900 - 89.9500 1-Yr Rtn: +16.74%

Stock Chart for SAN

No chart data available.
  • SAN:FP 82.0000
  • 1D
  • 1M
  • 1Y
82.2600
Interactive SAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SAN

Current P/E Ratio (ttm) 26.2484
Estimated P/E(12/2014) 15.8515
Relative P/E vs. CAC 1.0137
Earnings Per Share (EUR) (ttm) 3.1240
Est. EPS (EUR) (12/2014) 5.1730
Est. PEG Ratio 2.3790
Market Cap (M EUR) 108,188.13
Shares Outstanding (M) 1,319.37
30 Day Average Volume 3,414,878
Price/Book (mrq) 2.0975
Price/Sale (ttm) 3.3000
Dividend Indicated Gross Yield 3.41%
Cash Dividend (EUR) 2.8000
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth 4.94%
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SAN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for SAN

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Serge Daniel WeinbergInterim CEOAnne C BealChief Patient Officer
Elias A ZerhouniPres:Global Research & DevJerome ContamineExec VP/CFO
More Company Profile & Key Executives for SAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil